C4 Therapeutics (CCCC) Earnings Date & Reports

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CCCC is expected to report earnings to rise 22.40% to -24 cents per share on October 29

C4 Therapeutics CCCC Stock Earnings Reports

Q3'26

Est.

$-0.24

Q1'26

Beat

by $0.05

Q4'25

Beat

by $0.11

Q3'25

Missed

by $0.03

Q2'25

Beat

by $0.03

The last earnings report on May 12 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 698.55K shares outstanding, the current market capitalization sits at 492.10M.

View a ticker or compare two or three

CCCC

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days